Is your pharmaceutical company ready for new regulations?
The pharmaceutical industry is facing regulatory changes in both the post-Brexit British and Northern Irish market and in the European Union, with new quality, health, and safety standards being introduced.
Pharmaceutical companies looking to sell medical devices on either market will have to ensure that their products adhere to the respective regulations.
Compliance with the new regulations will be mandatory by 2025, which means that changes to information leaflet sizes and artwork will be required over the next two years.